Alere i flu, Alere i
Recall Z-2095-2015, part of FDA recall event 71585. See Alere Scarborough's company page.
Alere Scarborough, Inc. dba Binax, Inc. started this Class II device recall on Jun 26, 2015 (voluntary: firm initiated); FDA lists it as terminated, terminated Sep 15, 2015.
- Classification: Class II
- Started: Jun 26, 2015
- Status: Terminated
Risk of false negative results due to microbial growth in the Sample Receiver of one lot of the Alere i Influenza A & B kit
- Product
- Alere i flu, Alere i, Alere Influenza A & B; Part Number (PN) 425-024 The Alere" i Influenza A & B assay, performed on the Alere" i Instrument, is a rapid molecular in vitro diagnostic test utilizing an isothermal nucleic acid amplification technology for the qualitative detection and discrimination of influenza A and B viral RNA in nasal swabs from patients with signs and symptoms of respiratory infection. It is intended for use as an aid in the differential diagnosis of influenza A and B viral infections in humans, in conjunction with clinical and epidemiological risk factors. The assay is not intended to detect the presence of influenza C virus.
- Quantity
- 257 Kits
- Lots and codes
- Lot Number 0073853 (US distribution only)
- Distribution
- Nationwide Distribution including AR CA CO CT FL GA IA IL IN KS KY LA MA MD ME MO MS NC NE NJ NY OH PA SC TX VA WA WY.
- Recalling firm
- Alere Scarborough, Inc. dba Binax, Inc., Scarborough, ME, United States
- How the firm notified
- Letter
- FDA classified
- Jul 16, 2015
Newest first, one product per recall event; search them all
- Alere i Influenza A & B Product Usage: The Alere i Influenza A and B assay, performed on the Alere i Instrument, is…Z-1677-2015 · Class II · Apr 22, 2015 · Terminated
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports